News | April 14, 2024
Briefs: Sun Pharma and Kimia Biosciences
Sun Pharma's Dadra facility receives OAI status from US FDA
Sun Pharma's Dadra facility receives OAI status from US FDA
First and only AKT inhibitor approved in Japan for breast cancer patients with specific biomarker alterations
From only 80 Jan Aushadhi Kendras in 2014, there are around 11,000 units operating across the country today
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
Collaborative Research in AYUSH is extremely important as it bridges the gap between traditional knowledge and modern scientific research
Launch of Indian public health standards for Ayush healthcare facilities
ICMR’s budgetary allowance has increased by 4-fold in the past 10 years, showcasing our commitment towards Health Research
The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series
Global Initiative on Digital Health (GIDH) was launched by the WHO and the Government of India during the G20 Health Working Group meeting in Gandhinagar last year
AIIMS Rewari is a 750-bed hospital complex which includes a 100 seat medical college, a 60 seat nursing college, a 30-bed AYUSH block
Subscribe To Our Newsletter & Stay Updated
